In vivo experimental metastatic assays demonstrated that except in the case of MC38 cells [22] and HT29 cells (Figure 1E), CEACAM1-L did not change the outcome of metastasis in other CRC cells tested (Supplementary Figure 1). This evidence concerns the gene CEACAM1 and colorectal carcinoma.